Method for the management of hyperplasia

Details Method for the management of hyperplasia Method for the management of hyperplasia

1988-09-09

1990-10-09

Ryan, Patrick

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424431, 424432, 424433, 604 54, 604 55, 604 56, 604285, 604288, A61K 31505

Patent

active

049619314

ABSTRACT:
The invention is for a vaginal dispenser comprising a wall surrounding an internal lumen and having a pair of ends with one end placed inside the other end to form a closed dispenser. A vaginally administrable beneficial agent is housed in the lumen for release by the dispenser over time.

REFERENCES:
patent: 3733407 (1973-05-01), Segre
patent: 3797492 (1974-03-01), Place
patent: 3828781 (1974-08-01), Rothman
patent: 3896819 (1975-07-01), Zaffaroni et al.
patent: 3911911 (1975-10-01), Scommenga
patent: 3920805 (1975-11-01), Roseman
patent: 3938515 (1976-02-01), Leeper et al.
patent: 3967618 (1976-07-01), Zaffaroni
patent: 3991760 (1976-11-01), Drobish et al.
patent: 3995633 (1976-12-01), Gougeon
patent: 3995634 (1976-12-01), Drobish
patent: 4145416 (1979-03-01), Lachnit-Fixson et al.
patent: 4155991 (1979-05-01), Schopflin et al.
patent: 4198634 (1980-04-01), Jernigan et al.
patent: 4198976 (1980-04-01), Drobish et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4215691 (1980-08-01), Wong
patent: 4237885 (1980-12-01), Wong et al.
patent: 4256236 (1981-05-01), Pacella
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4286587 (1981-09-01), Wong
patent: 4292965 (1981-10-01), Nash et al.
patent: 4315925 (1982-02-01), Hussain et al.
patent: 4326510 (1982-04-01), Buckles
patent: 4372951 (1983-02-01), Vorys
patent: 4402695 (1983-09-01), Wong
patent: 4425339 (1984-01-01), Pitchford
patent: 4596576 (1986-06-01), de Nijs
patent: 4629449 (1986-12-01), Wong
Kempers, Roger D., "The Menopause", pp. 209-215; Textbook of Gynecology, Edited by De Alvarez, M.D., Lea & Febiger, (1977), Philadelphia.
Gambrell, Jr., M.D., R. Don, "The Menopause: Benefits and Risk of Estrogen-Progestogen Replacement Therapy", Fertility and Sterility, vol. 37, No. 4, (Apr. 1982), pp. 457-473.
Whitehead, M. I. & Campbell, S., "Endometrial Histology, Uterine Bleeding and Oestrogen Levels in Menopausal Women Receiving Oestrogen Therapy and Oestrogen Progestogen Therapy", pp. 65-80, Endometrial Cancer, edited by Brush, M. G., King, R. J. B. & Taylor, R. W., (1977), Bailliere Tindall-London.
King, R. J. B., Whitehead, M. I., Campbell, S. & Minardi, Jane, "Effects of Estrogens and Progestogens on the Biochemistry of the Post-Menopausal Endometrium," pp. 111-119, The Role of Estrogen/Progestogen in the Management of the Menopause, Proceedings of a Symposium held at the U. of Sheffield on Mar. 16, 1987, MTP Press, Ltd., Lancaster, England.
Gal, M.D., David, Edman, M.D., Clare D., et al., "Long-Term Effect of Megestrol Acetate in the Treatment of Endometrial Hyperplasia," pp. 316-322, Am. J. Obstet. Gynecol., vol. 146, No. 3, (Jun., 1983).

Affiliated with

Also associated with

Rating

Method for the management of hyperplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the management of hyperplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the management of hyperplasia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-972361